MAOA/HDAC-IN-1 is a dual inhibitor of monoamine oxidase A (MAOA) and histone deacetylase (HDAC); it is used in glioma research; it serves as a click chemistry reagent containing an alkyne group that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules.